These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2238717)

  • 41. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Changes in the immune status of peptic ulcer patients after combined treatment including deep massage].
    Aksenova AM; Teslenko OI; Boganskaia OA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (2):19-20. PubMed ID: 10358996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current trends in medical therapy of gastroduodenal ulcer].
    Grassi M; Fraioli A; Messina B
    Clin Ter; 1987 Dec; 123(6):475-86. PubMed ID: 2902954
    [No Abstract]   [Full Text] [Related]  

  • 44. [Causes of postoperative recurrence and therapy of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP; Vdovichenko VI
    Klin Med (Mosk); 1990 Jan; 68(1):136-44. PubMed ID: 2335916
    [No Abstract]   [Full Text] [Related]  

  • 45. [What is the role of H2 receptor blockers today in ulcer therapy?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
    [No Abstract]   [Full Text] [Related]  

  • 46. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 48. [Current locally acting agents in the treatment of peptic ulcer].
    Ryss ES
    Klin Med (Mosk); 1986 Aug; 64(8):18-27. PubMed ID: 2878103
    [No Abstract]   [Full Text] [Related]  

  • 49. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
    Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
    Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of reflex muscle massage on the body regulatory processes of peptic ulcer patients with concomitant diseases].
    Aksenova AM; Romanova MM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (6):24-6. PubMed ID: 9987972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Local factors in the pathogenesis of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1988 May; 66(5):25-30. PubMed ID: 3047490
    [No Abstract]   [Full Text] [Related]  

  • 52. Stress ulcer prophylaxis. Do critically ill patients need it?
    DePriest JL
    Postgrad Med; 1995 Oct; 98(4):159-61, 165-6, 168. PubMed ID: 7567717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal bleeding in the critically ill: a penny saved...
    Baldwin TL; Clement DJ
    Am J Gastroenterol; 1995 Aug; 90(8):1355-6. PubMed ID: 7639253
    [No Abstract]   [Full Text] [Related]  

  • 54. The development of clinical practice guidelines for treatment of peptic acid diseases in a VA ambulatory care clinic--a comment.
    Holt RJ; Fort J
    Pharmacotherapy; 1996; 16(3):480-1; discussion 482-3. PubMed ID: 8726612
    [No Abstract]   [Full Text] [Related]  

  • 55. Peptic ulcer disease in children and adolescents: evolving dilemmas.
    Nord KS
    J Pediatr Gastroenterol Nutr; 1983; 2(3):397-9. PubMed ID: 6312009
    [No Abstract]   [Full Text] [Related]  

  • 56. [Ulcer prevention during anti-rheumatism therapy and in intensive medicine].
    Koelz HR
    Schweiz Rundsch Med Prax; 1994 Jun; 83(25-26):768-71. PubMed ID: 8029591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agents with tricyclic structures for treating peptic ulcer disease.
    Berardi RR; Caplan NB
    Clin Pharm; 1983; 2(5):425-31. PubMed ID: 6354568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New approach to the treatment and prophylaxis of NSAID-induced gastropathies in ambulatory practics].
    Burkov SG; Arutiunov AT; Nikiforov PA
    Eksp Klin Gastroenterol; 2007; (5):96-102. PubMed ID: 18389605
    [No Abstract]   [Full Text] [Related]  

  • 59. [Long-term drug therapy of peptic ulcer disease. A current review of the status of various anti-ulcer drugs].
    Rohner HG; Rüther N
    Fortschr Med; 1986 Dec; 104(3):933-6. PubMed ID: 2881868
    [No Abstract]   [Full Text] [Related]  

  • 60. [The characteristics of the present-day course of peptic ulcer in childhood and the approaches to the staged treatment of patients].
    Zakomernyĭ AG
    Ter Arkh; 1995; 67(2):23-6. PubMed ID: 7725252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.